Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum reference price

Authors
Citation
V. Atella, Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum reference price, HEALTH POLI, 50(3), 2000, pp. 197-218
Citations number
24
Categorie Soggetti
Public Health & Health Care Science","Health Care Sciences & Services
Journal title
HEALTH POLICY
ISSN journal
01688510 → ACNP
Volume
50
Issue
3
Year of publication
2000
Pages
197 - 218
Database
ISI
SICI code
0168-8510(200001)50:3<197:DCCPII>2.0.ZU;2-U
Abstract
The aim of this paper is to evaluate the long-run effects of the minimum re ference price (MRP) policy adopted recently in Italy in order to contain dr ug expenditure. This evaluation is based upon an econometric model of the d emand for drugs in Italy, based on data covering the period from 1963 to 19 94. With this model we can assess not only the effects of the MRP policy on expenditure trends, but also its redistributive effects between consumers, firms and the government. Results from the simulation exercises have prove d that the tendency of the pharmaceutical expenditure is to raise again aft er few years of control, even with the introduction of the MRP. Changes in the up-ward trends can be obtained only with joint intervention on both sup ply and demand side. At the same time, a cost containment policy that acts on prices can have serious implications in terms of welfare. (C) 2000 Elsev ier Science Ireland Ltd. All rights reserved.